Another sialyltransferase inhibitor, Soyasaponin I (SsaI), that targets α2,3-STs, in particular ST3Gal I, inhibited tumor cell migration and dissemination in the in vivo mouse model with transplanted ovarian cancer cells [27]. The gene discussed is ST3GAL1; the disease is neoplasm.